MUTATION

Completed

The objectives of the MUTATION project are to support the development of new cMUT medical probes combining therapy (ultrasonic power) with ultrasound imaging (dual-mode transducers), and to speed up the marketing of these new systems around the world. two flagship applications for which the project's industrial partners are the leaders: the treatment of localized prostate cancer under the endocavitary approach (endocavity probes) with the partner Edap-TMS and the treatment of interstitial brain tumors (interstitial probes) with the Carthéra partner. The proofs of concepts have already been realized by all the industrial partners in the framework of several ANR research projects, always in collaboration with LabTAU whose expertise in the field of therapeutic ultrasound is recognized worldwide. The industrial development of this new cMUT technology for therapy represents a new activity niche for the Vermon project leader, an industrial and marketing reinforcement for EDAP and Carthéra

Project benefits

Publication scientifique : 120

Produit / Prototype : 8

Action de communication : 12

Nouveau projet : 4

Rapport final : 4

People involved in the project

Project leader

No member partner

CARTHERA

EDAP-TMS

LABORATOIRE LABTAU INSERM U1032

Information of the project

Start of the project on01 / 09 / 2013 | End of project on31 / 08 / 2017


Strategic business lines

Bâtiments intelligents

Matériaux et composants pour l'électronique


Referent of the project

Nicolas POUSSET
Directeur Technique

07 86 53 38 70

nicolas.pousset-s2e2-ext@st.com

Centre-Val de loire